erythromycin has been researched along with cyproterone in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (62.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Fanta, D; Niebauer, G | 1 |
| Cunliffe, WJ | 1 |
| Rajka, G | 1 |
| Gerny, H | 1 |
2 review(s) available for erythromycin and cyproterone
| Article | Year |
|---|---|
[Progress in medicine in individual presentations, XI. Modern forms of therapy in acne].
Topics: Acne Vulgaris; Androgen Antagonists; Bacterial Vaccines; Benzoyl Peroxide; Cyproterone; Erythromycin; Estrogens; gamma-Globulins; Levamisole; Propionibacterium; Tetracycline; Tretinoin | 1977 |
Acne vulgaris. The past. The present and the future.
Topics: Acne Vulgaris; Androgen Antagonists; Androgens; Benzoyl Peroxide; Cyproterone; Cyproterone Acetate; Dermatitis, Seborrheic; Drug Combinations; Erythromycin; Ethinyl Estradiol; Female; Humans; Isotretinoin; Male; Propionibacterium acnes; Sebum; Tetracycline; Tretinoin | 1985 |
6 other study(ies) available for erythromycin and cyproterone
| Article | Year |
|---|---|
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
On therapeutic approaches to some special types of acne.
Topics: Acne Vulgaris; Administration, Topical; Adolescent; Adult; Androgen Antagonists; Anti-Inflammatory Agents; Benzoyl Peroxide; Clindamycin; Cyproterone; Cyproterone Acetate; Diazepam; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Erythromycin; Ethinyl Estradiol; Female; Humans; Hydrocortisone; Male; Sulfamethoxazole; Tetracycline; Tretinoin; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1985 |
[Experiences in dermatologic practice with combined external treatment of acne with benzoyl peroxide and erythromycin].
Topics: Acne Vulgaris; Adolescent; Adult; Androgen Antagonists; Benzoyl Peroxide; Combined Modality Therapy; Cyproterone; Cyproterone Acetate; Drug Combinations; Drug Therapy, Combination; Erythromycin; Ethinyl Estradiol; Female; Humans; Male; Peroxides; Tetracycline; Ultraviolet Therapy | 1984 |
Acne today.
Topics: Acne Vulgaris; Administration, Oral; Administration, Topical; Benzoyl Peroxide; Cyproterone; Cyproterone Acetate; Double-Blind Method; Erythromycin; Female; Humans; Isotretinoin; Male; Tetracycline; Tretinoin | 1984 |